(S)-UH-301 antagonizes (R)-8-OH-DPAT-induced cardiovascular effects in the rat.
L Björk, S Lindgren, U Hacksell, T Lewander
Index: Eur. J. Pharmacol. 199 , 367, (1991)
Full Text: HTML
Abstract
The 5-HT1A-receptor antagonist (S)-UH-301 (S)-5-fluoro-8-hydroxy-2- (dipropylamino)tetralin) completely antagonized the hypotension and bradycardia induced by (R) = 8-OH DPAT [R)-8-hydroxy-2- (dipropylamino)tetralin) in conscious rats. (S)-UH-301 alone induced a weak hypertension, which might be due to its 5-HT1A-receptor antagonistic properties. (R)-UH-301 induced effects similar to those of (R)-8-OH DPAT, i.e., a short initial phase of hypertension followed by a long-lasting hypotension and bradycardia. Thus, (R)-UH-301 behaves as a 5-HT1A-receptor agonist and (S)-UH-301 as a 5-HT1A-receptor antagonist, abolishing the effects induced by (R)-8-OH DPAT.
Related Compounds
Related Articles:
1999-01-01
[Eur. Neuropsychopharmacol. 9 , 15-19, (1999)]
1991-07-01
[J. Pharmacol. Exp. Ther. 258 , 58, (1991)]
1993-04-01
[Naunyn Schmiedebergs Arch. Pharmacol. 347 , 353-362, (1993)]
Synthesis and pharmacology of the enantiomers of UH301: opposing interactions with 5-HT1A receptors.
1996-01-01
[Chirality 8 , 531-544, (1996)]